Cara Doba Injv is primarily indicated in conditions like Hypertension, Hypertension in pregnancy, Hypertensive emergencies, Primary hypertension, Renal hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Postmenupausal flushing.
Cara Doba Inj is contraindicated in conditions like Hepatic disease, Hypersensitivity, Postural hypotension.
The severe or irreversible adverse effects of Cara Doba Inj , which aive rise to further complications include Thrombocytopenia, Pancreatitis, Granulocytopenia, Depression, Acute colitis. Cara Doba Inj produces potentially life-threatening effects which include Hemolytic anemia, Hepatitis, Myocarditis. which are responsible for the discontinuation of Cara Doba Inj therapy.The signs and symptoms that are produced after the acute overdosage of Cara Doba Inj include Bradycardia, Hypotension, Coma, Dry mouth, Hypothermia, Dizziness, Weakness. The symptomatic adverse reactions produced by Cara Doba Inj are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Diarrhea, Fever, Skin rashes, Dry mouth, Sedation, Impotence, Loss of libido, Nasal congestion, Light headedness, Galactorrhea, Eosinophilia, Failure of ejaculation.
The patient should have Hemoglobin, Hemocrit and ESR assessed before and during Cara Doba Inj therapy because of the risk of the hemolytic anemia. The drug should be used with caution in the patient with hemolytic anemia and autoimmune disease, if present, discontinue the therapy. The drug should be used with caution in the patient with hepatic or renal impairment, pheochromocytoma, and cardiovascular or cerebrovascular insufficiency, major Depression. Cara Doba Inj can cause the sedation, so the patient should be warned that impaired physical coordination and/or reduced mental alertness can affect their ability to operate machinery or drive a vehicle.